Colorado

Back to map

Showing 1-10 of 24 grants

Title Institution Researcher Program Duration Total Award Amount
Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell Colorado School of Mines Nikki Farnsworth Cures 01-April-2023 to 31-December-2026 $900.000,00
Advanced CGM analyses for longitudinal monitoring of early-stage Type 1 Diabetes Regents of the University of Colorado Andrea Steck Cures 01-October-2024 to 30-September-2027 $900.000,00
Improving Early Type 1 Diabetes Management Through Dual Glucose–Ketone Monitoring: Metabolic Characterization, Prediction of Progression, and Patient Experience Regents of the University of Colorado Brigitte Frohnert Cures 01-August-2026 to 31-July-2029 $1.500.000,00
Clinic-based sleep screening and intervention to improve sleep health in adolescents with type 1 diabetes Regents of the University of Colorado Erin Cobry Transportfolio 01-April-2022 to 31-March-2027 $750.000,00
Use of Adaptive Learning with Ultra-Rapid-Acting Concentrated Insulin for Personalized Fully Closed-Loop Glycemic Control in Type 1 Diabetes Regents of the University of Colorado Gregory Forlenza Improving Lives 01-July-2026 to 30-June-2029 $3.928.617,55
Genetically engineered human pluripotent stem cells enabling programmable β-cell differentiation for type 1 diabetes therapy. Regents of the University of Colorado Han Zhu Cures 01-October-2026 to 30-September-2029 $749.996,48
Cognitive behavioral therapy to address anxiety in pre symptomatic type 1 diabetes Regents of the University of Colorado Holly O’Donnell Cures 01-July-2024 to 30-June-2027 $600.000,00
Engaging Interest Holders to Measure Psychological Impacts and Patient-Reported Outcomes of Treatment with Disease-Modifying Therapy in T1D Regents of the University of Colorado Holly O’Donnell Cures 01-August-2026 to 31-July-2029 $846.023,00
EFFICACY AND SAFETY OF ONCE WEEKLY SEMAGLUTIDE IN ADULTS WITH OBESITY AND INADEQUATELY CONTROLLED TYPE 1 DIABETES USING HYBRID CLOSED-LOOP SYSTEM Regents of the University of Colorado Janet Snell-Bergeon Improving Lives 01-November-2022 to 31-October-2027 $2.282.771,83
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes Regents of the University of Colorado Jessica Kendrick Improving Lives 01-October-2022 to 31-October-2027 $899.235,00